MedPath

Cerebellar rTMS for Essential Tremor

Not Applicable
Completed
Conditions
Essential Tremor
Interventions
Other: Sham (electrical stimulation)
Other: Bilateral 1 Hz Cerebellar rTMS
Registration Number
NCT02704793
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Essential tremor (ET) is a low-mortality, though truly burdensome and debilitating condition which is known to be the second most common movement disorder of the adult population only after restless legs syndrome. The prevalence of the disorder in all age groups has been estimated to be 0.9%. Repetitive transcranial magnetic stimulation (rTMS) is an almost safe technique which has been used in diagnosis and treatment of many neurologic and psychiatric conditions. Recent studies have shown that cerebellum has a significant role in development of ET and that rTMS could exert therapeutic effects on its motor symptoms. In this study researchers will recruit at least 30 subjects among patients visiting at the Specialty Clinic of Mashhad Medical University according to researchers exclusion and inclusion criteria and after signing a written informed consent, will randomly be assigned to either real or sham rTMS. On the real rTMS arm, patients will be treated with 900 pulses of 1 Hz rTMS on 90% of resting motor threshold (RMT) delivered over each cerebellar hemisphere for 5 consecutive days and sham treatment will be performed with the same protocol using a small device placed on the TMS coil (not visible to the patients) producing electrical stimulation (less than 3 mili amperes), to simulate the sensation of real TMS. Subject's ear will be protected with earplugs during both real and sham stimulations. After 2 months of follow-up, patients will undergo crossover and receive the other treatment as described above. Patients would be assessed using Fahn-Tolosa-Marin scale at the baseline and again on days 5, 12, and 30 after each real or sham treatment session by a blinded researcher. Data will be analysed by another researcher who is also blind.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • having a diagnosis of essential tremor (ET) based on Movement Disorder Society criteria, involving at least one hand.
  • 18 years or above
  • cognitively eligible to give informed consent of participation in the trial.
Read More
Exclusion Criteria
  • Cardiac pace-maker or other implanted magnetic device or having other contraindications of performing a routine non-contrast MRI
  • skin defect at the occipital area preventing placement of a coil
  • Currently pregnant or plan for pregnancy in the next 6 months
  • History of seizure
  • Other comorbid medical conditions capable of producing or enhancing tremor
  • advanced cardiac, renal, hepatic or other disabling conditions making patient physical unable to participate in examination and receiving the intervention
  • Use of new drugs with potential effect on tremor
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sham (electrical stimulation)Sham (electrical stimulation)Sham treatment will be performed with the same protocol using a small device placed on the TMS coil (not visible to the patients) producing electrical stimulation (less than 3 mili amperes), to simulate the sensation of real TMS.
Bilateral 1 Hz Cerebellar rTMSBilateral 1 Hz Cerebellar rTMSPatients will be treated with 900 pulses of 1 Hz rTMS on 90% of resting motor threshold (RMT) delivered over each cerebellar hemisphere for 5 consecutive days.
Primary Outcome Measures
NameTimeMethod
change in score of Fahn-Tolosa-Marin scaleat the baseline and on days 5, 12, and 30 after each real or sham treatment session.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Neurology, Ghaem Hospital

🇮🇷

Mashhad, Razavi Khorasan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath